Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-677 (Ibutamoren) vs Ipamorelin - Pepdex

Field Left Right Category GH-axis GH-axis Half-life ~24 hours ~2 hours Route Oral Subcutaneous Schedule Once daily 1-3x daily Cycle length 8-12 weeks on, 4 weeks off 8-12 weeks on, 4 weeks off Dose 10-25 mg orally, once daily, taken before bed. 100-300 mcg sub-q, 1-3x daily. Pre-bed dose is the most important pulse. FDA Not FDA approved. Reached Phase 2 trials, never approved. Not FDA approved. WADA Banned (S2) Banned (S2) Natty? Not natty Not natty Prescribed Not prescribed in conventional medicine. Sometimes offered by anti-aging clinics off-label. Some anti-aging and longevity clinics prescribe via compounding pharmacies, off-label. Top side effects Aggressive appetite stimulation; Water retention / bloat; Numb/tingling hands (carpal-tunnel-like) Head-rush at injection; Mild hunger pulse 30 min post-dose; Tingling in hands rarely

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Field

Left

Right

Category

GH-axis

GH-axis

Half-life

~24 hours

~2 hours

Route

Oral

Subcutaneous

Schedule

Once daily

1-3x daily

Cycle length

8-12 weeks on, 4 weeks off

8-12 weeks on, 4 weeks off

Dose

10-25 mg orally, once daily, taken before bed.

100-300 mcg sub-q, 1-3x daily. Pre-bed dose is the most important pulse.

FDA

Not FDA approved. Reached Phase 2 trials, never approved.

Not FDA approved.

WADA

Banned (S2)

Banned (S2)

Natty?

Not natty

Not natty

Prescribed

Not prescribed in conventional medicine. Sometimes offered by anti-aging clinics off-label.

Some anti-aging and longevity clinics prescribe via compounding pharmacies, off-label.

Top side effects

Aggressive appetite stimulation; Water retention / bloat; Numb/tingling hands (carpal-tunnel-like)

Head-rush at injection; Mild hunger pulse 30 min post-dose; Tingling in hands rarely

Connected topics

Follow this recovery question